News|Articles|January 2, 2024
Reducing Risk in Bioproduction with Facilities Equivalency (Jan 2024)
Author(s)Thermo Fisher Scientific
Media manufacturers must offer global redundancy at harmonized manufacturing facilities to enable streamlined capabilities–especially for their customers outsourcing proprietary cell culture media formulations. This paper details Thermo Fisher’s manufacturing equivalency approach utilized at two global facilities located in Miami, Florida, and Grand Island, New York.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Content
Trending on Pharmaceutical Technology
1
How ten23 health is Advancing Patient-Centric Drug Delivery
2
FDA, Duke University Planning Epinephrine Access Workshop for December
3
Drug Solutions Podcast: Innovations in Orphan Drugs for Rare Diseases
4
Industry Expert Panel Weighs CNPV Benefits, Risks, and Readiness: Part II
5
